Endometrial receptivity with different support protocols for the luteal phase in ovarian stimulation cycles in which final oocyte maturation is carried out with GnRH analogues. Analysis by endometrial microarrays.

Trial Profile

Endometrial receptivity with different support protocols for the luteal phase in ovarian stimulation cycles in which final oocyte maturation is carried out with GnRH analogues. Analysis by endometrial microarrays.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2016

At a glance

  • Drugs Estradiol valerate (Primary) ; Lutropin alfa (Primary) ; Progesterone (Primary) ; Triptorelin (Primary) ; Chorionic gonadotropin
  • Indications Ovarian hyperstimulation syndrome
  • Focus Therapeutic Use
  • Acronyms ERAMAD
  • Most Recent Events

    • 25 Oct 2016 Status changed from recruiting to completed.
    • 22 Feb 2012 Additional lead trial centres added as reported by European Clinical Trials Database.
    • 22 Feb 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2011-003250-34).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top